SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)

Clin Transl Oncol. 2024 Nov;26(11):2877-2901. doi: 10.1007/s12094-024-03605-2. Epub 2024 Aug 7.

Abstract

The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.

Keywords: Anticoagulation; Cancer; Direct oral anticoagulants; Guidelines; Low-molecular-weight heparins; Venous thromboembolism.

Publication types

  • Practice Guideline

MeSH terms

  • Anticoagulants* / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Medical Oncology* / standards
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Societies, Medical
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / etiology
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight